|
1
|
Lechner M, Frampton GM, Fenton T, Feber A,
Palmer G, Jay A, Pillay N, Forster M, Cronin MT, Lipson D, et al:
Targeted next-generation sequencing of head and neck squamous cell
carcinoma identifies novel genetic alterations in HPV+ and HPV-
tumors. Genome Med. 5:492013. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lechner M, Fenton T, West J, Wilson G,
Feber A, Henderson S, Thirlwell C, Dibra HK, Jay A, Butcher L, et
al: Identification and functional validation of HPV-mediated
hypermethylation in head and neck squamous cell carcinoma. Genome
Med. 5:152013. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Agrawal N, Frederick MJ, Pickering CR,
Bettegowda C, Chang K, Li RJ, Fakhry C, Xie TX, Zhang J, Wang J, et
al: Exome sequencing of head and neck squamous cell carcinoma
reveals inactivating mutations in NOTCH1. Science. 333:1154–1157.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stransky N, Egloff AM, Tward AD, Kostic
AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C,
McKenna A, et al: The mutational landscape of head and neck
squamous cell carcinoma. Science. 333:1157–1160. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Worsham MJ, Chen KM, Ghanem T, Stephen JK
and Divine G: Epigenetic modulation of signal transduction pathways
in HPV-associated HNSCC. Otolaryngol Head Neck Surg. 149:409–416.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pyeon D, Newton MA, Lambert PF, den Boon
JA, Sengupta S, Marsit CJ, Woodworth CD, Connor JP, Haugen TH,
Smith EM, et al: Fundamental differences in cell cycle deregulation
in human papillomavirus-positive and human papillomavirus-negative
head/neck and cervical cancers. Cancer Res. 67:4605–4619. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gillison ML: Human
papillomavirus-associated head and neck cancer is a distinct
epidemiologic, clinical, and molecular entity. Semin Oncol.
31:744–754. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nguyen NP, Chi A, Nguyen LM, Ly BH,
Karlsson U and Vinh-Hung V: Human papillomavirus-associated
oropharyngeal cancer: A new clinical entity. QJM. 103:229–236.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sartor MA, Dolinoy DC, Jones TR, Colacino
JA, Prince ME, Carey TE and Rozek LS: Genome-wide methylation and
expression differences in HPV(+) and HPV(−) squamous cell carcinoma
cell lines are consistent with divergent mechanisms of
carcinogenesis. Epigenetics. 6:777–787. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Richards KL, Zhang B, Baggerly KA, Colella
S, Lang JC, Schuller DE and Krahe R: Genome-wide hypomethylation in
head and neck cancer is more pronounced in HPV-negative tumors and
is associated with genomic instability. PLoS One. 4:e49412009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lleras RA, Smith RV, Adrien LR, Schlecht
NF, Burk RD, Harris TM, Childs G, Prystowsky MB and Belbin TJ:
Unique DNA methylation loci distinguish anatomic site and HPV
status in head and neck squamous cell carcinoma. Clin Cancer Res.
19:5444–5455. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fakhry C, Westra WH, Li S, Cmelak A, Ridge
JA, Pinto H, Forastiere A and Gillison ML: Improved survival of
patients with human papillomavirus-positive head and neck squamous
cell carcinoma in a prospective clinical trial. J Natl Cancer Inst.
100:261–269. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gubanova E, Brown B, Ivanov SV, Helleday
T, Mills GB, Yarbrough WG and Issaeva N: Downregulation of SMG-1 in
HPV-positive head and neck squamous cell carcinoma due to promoter
hypermethylation correlates with improved survival. Clin Cancer
Res. 18:1257–1267. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Stephen JK, Chen KM, Shah V, Havard S, Lu
M, Schweitzer VP, Gardner G and Worsham MJ: Human papillomavirus
outcomes in an access-to-care laryngeal cancer cohort. Otolaryngol
Head Neck Surg. 146:730–738. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stephen JK, Divine G, Chen KM, Chitale D,
Havard S and Worsham MJ: Significance of p16 in site-specific HPV
positive and HPV negative head and neck squamous cell carcinoma.
Cancer Clin Oncol. 2:51–61. 2013.PubMed/NCBI
|
|
16
|
Worsham MJ, Stephen JK, Chen KM, Mahan M,
Schweitzer V, Havard S and Divine G: Improved survival with HPV
among African Americans with oropharyngeal cancer. Clin Cancer Res.
19:2486–2492. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sandoval J, Heyn H, Moran S, Serra-Musach
J, Pujana MA, Bibikova M and Esteller M: Validation of a DNA
methylation microarray for 450,000 CpG sites in the human genome.
Epigenetics. 6:692–702. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Horner MJ, Ries LAG, Krapcho M, Neyman N,
Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A,
Miller BA, Lewis DR, Eisner MP, Stinchcomb DG and Edwards BK: SEER
cancer statistics review, 1975–2006, section 16: Melanoma of the
SkinBased on November 2008 SEER data submission, posted to the SEER
web site. 2009, National Cancer Institute; Bethesda, MD: Retrieved
March 29, 2010, from. http://seer.cancer.gov/csr/1975_2006/2009.
|
|
19
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Brockstein B, Haraf DJ, Rademaker AW, Kies
MS, Stenson KM, Rosen F, Mittal BB, Pelzer H, Fung BB, Witt ME, et
al: Patterns of failure, prognostic factors and survival in
locoregionally advanced head and neck cancer treated with
concomitant chemoradiotherapy: A 9-year, 337-patient,
multi-institutional experience. Ann Oncol. 15:1179–1186. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hashibe M, Brennan P, Benhamou S,
Castellsague X, Chen C, Curado MP, Dal Maso L, Daudt AW, Fabianova
E, Fernandez L, et al: Alcohol drinking in never users of tobacco,
cigarette smoking in never drinkers and the risk of head and neck
cancer: Pooled analysis in the International Head and Neck Cancer
Epidemiology Consortium. J Natl Cancer Inst. 99:777–789. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hashibe M, Brennan P, Chuang SC, Boccia S,
Castellsague X, Chen C, Curado MP, Dal Maso L, Daudt AW, Fabianova
E, et al: Interaction between tobacco and alcohol use and the risk
of head and neck cancer: Pooled analysis in the International Head
and Neck Cancer Epidemiology Consortium. Cancer Epidemiol
Biomarkers Prev. 18:541–550. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gillison ML and Lowy DR: A causal role for
human papillomavirus in head and neck cancer. Lancet.
363:1488–1489. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ang KK, Harris J, Wheeler R, Weber R,
Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C,
et al: Human papillomavirus and survival of patients with
oropharyngeal cancer. N Engl J Med. 363:24–35. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Marur S, D'Souza G, Westra WH and
Forastiere AA: HPV-associated head and neck cancer: A virus-related
cancer epidemic. Lancet Oncol. 11:781–789. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mydlarz WK, Hennessey PT and Califano JA:
Advances and perspectives in the molecular diagnosis of head and
neck cancer. Expert Opin Med Diagn. 4:53–65. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hafkamp HC, Speel EJ, Haesevoets A, Bot
FJ, Dinjens WN, Ramaekers FC, Hopman AH and Manni JJ: A subset of
head and neck squamous cell carcinomas exhibits integration of HPV
16/18 DNA and overexpression of p16INK4A and p53 in the absence of
mutations in p53 exons 5–8. Int J Cancer. 107:394–400. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Smith EM, Wang D, Kim Y, Rubenstein LM,
Lee JH, Haugen TH and Turek LP: P16INK4a expression, human
papillomavirus and survival in head and neck cancer. Oral Oncol.
44:133–142. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ragin CC, Taioli E, Weissfeld JL, White
JS, Rossie KM, Modugno F and Gollin SM: 11q13 amplification status
and human papillomavirus in relation to p16 expression defines two
distinct etiologies of head and neck tumours. Br J Cancer.
95:1432–1438. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gillison ML, D'Souza G, Westra W, Sugar E,
Xiao W, Begum S and Viscidi R: Distinct risk factor profiles for
human papillomavirus type 16-positive and human papillomavirus type
16-negative head and neck cancers. J Natl Cancer Inst. 100:407–420.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cancer Genome Atlas Network, .
Comprehensive genomic characterization of head and neck squamous
cell carcinomas. Nature. 517:576–582. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lum PY, Chen Y, Zhu J, Lamb J, Melmed S,
Wang S, Drake TA, Lusis AJ and Schadt EE: Elucidating the murine
brain transcriptional network in a segregating mouse population to
identify core functional modules for obesity and diabetes. J
Neurochem. 97:(Suppl 1). S50–S62. 2006. View Article : Google Scholar
|
|
33
|
Nilsson EE, Savenkova MI, Schindler R,
Zhang B, Schadt EE and Skinner MK: Gene bionetwork analysis of
ovarian primordial follicle development. PLoS One. 5:e116372010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen Y, Zhu J, Lum PY, Yang X, Pinto S,
MacNeil DJ, Zhang C, Lamb J, Edwards S, Sieberts SK, et al:
Variations in DNA elucidate molecular networks that cause disease.
Nature. 452:429–435. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gargalovic PS, Imura M, Zhang B, Gharavi
NM, Clark MJ, Pagnon J, Yang WP, He A, Truong A, Patel S, et al:
Identification of inflammatory gene modules based on variations of
human endothelial cell responses to oxidized lipids. Proc Natl Acad
Sci USA. 103:12741–12746. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Horvath S, Zhang B, Carlson M, Lu KV, Zhu
S, Felciano RM, Laurance MF, Zhao W, Qi S, Chen Z, et al: Analysis
of oncogenic signaling networks in glioblastoma identifies ASPM as
a molecular target. Proc Natl Acad Sci USA. 103:17402–17407. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Libby BJ, Reinholdt LG and Schimenti JC:
Positional cloning and characterization of Mei1, a
vertebrate-specific gene required for normal meiotic chromosome
synapsis in mice. Proc Natl Acad Sci USA. 100:15706–15711. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Davideau JL, Demri P, Hotton D, Gu TT,
MacDougall M, Sharpe P, Forest N and Berdal A: Comparative study of
MSX-2, DLX-5, and DLX-7 gene expression during early human tooth
development. Pediatr Res. 46:650–656. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Malewski T, Milewicz T, Krzysiek J,
Gregoraszczuk EL and Augustowska K: Regulation of Msx2 gene
expression by steroid hormones in human nonmalignant and malignant
breast cancer explants cultured in vitro. Cancer Invest.
23:222–228. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Satoh K, Ginsburg E and Vonderhaar BK:
Msx-1 and Msx-2 in mammary gland development. J Mammary Gland Biol
Neoplasia. 9:195–205. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu F, Ji F, Ji Y, Jiang Y, Sun X, Lu Y,
Zhang L, Han Y and Liu X: Dissecting the mechanism of colorectal
tumorigenesis based on RNA-sequencing data. Exp Mol Pathol.
98:246–253. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gumienny TL, Brugnera E, Tosello-Trampont
AC, Kinchen JM, Haney LB, Nishiwaki K, Walk SF, Nemergut ME, Macara
IG, Francis R, et al: CED-12/ELMO, a novel member of the
CrkII/Dock180/Rac pathway, is required for phagocytosis and cell
migration. Cell. 107:27–41. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jarzynka MJ, Hu B, Hui KM, Bar-Joseph I,
Gu W, Hirose T, Haney LB, Ravichandran KS, Nishikawa R and Cheng
SY: ELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange
factor, promote human glioma cell invasion. Cancer Res.
67:7203–7211. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Dulak AM, Stojanov P, Peng S, Lawrence MS,
Fox C, Stewart C, Bandla S, Imamura Y, Schumacher SE, Shefler E, et
al: Exome and whole-genome sequencing of esophageal adenocarcinoma
identifies recurrent driver events and mutational complexity. Nat
Genet. 45:478–486. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li H, Yang L, Fu H, Yan J, Wang Y, Guo H,
Hao X, Xu X, Jin T and Zhang N: Association between Gαi2 and
ELMO1/Dock180 connects chemokine signalling with Rac activation and
metastasis. Nat Commun. 4:17062013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yagi K, Akagi K, Hayashi H, Nagae G, Tsuji
S, Isagawa T, Midorikawa Y, Nishimura Y, Sakamoto H, Seto Y, et al:
Three DNA methylation epigenotypes in human colorectal cancer. Clin
Cancer Res. 16:21–33. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Vicaut E, Laemmel E and Stücker O: Impact
of serotonin on tumour growth. Ann Med. 32:187–194. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hambek M, Werner C, Baghi M, Gstöttner W
and Knecht R: Prestimulation of head and neck cancer cells with
growth factors enhances treatment efficacy. Anticancer Res.
26:1091–1095. 2006.PubMed/NCBI
|
|
49
|
Nishioka M, Bundo M, Koike S, Takizawa R,
Kakiuchi C, Araki T, Kasai K and Iwamoto K: Comprehensive DNA
methylation analysis of peripheral blood cells derived from
patients with first-episode schizophrenia. J Hum Genet. 58:91–97.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Deo RC, Schmidt EF, Elhabazi A, Togashi H,
Burley SK and Strittmatter SM: Structural bases for CRMP function
in plexin-dependent semaphorin3A signaling. EMBO J. 23:9–22. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Gelfand MV, Hong S and Gu C: Guidance from
above: Common cues direct distinct signaling outcomes in vascular
and neural patterning. Trends Cell Biol. 19:99–110. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Shih JY, Lee YC, Yang SC, Hong TM, Huang
CY and Yang PC: Collapsin response mediator protein-1: A novel
invasion-suppressor gene. Clin Exp Metastasis. 20:69–76. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Katagiri T and Takahashi N: Regulatory
mechanisms of osteoblast and osteoclast differentiation. Oral Dis.
8:147–159. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Siegel PM and Massagué J: Cytostatic and
apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev
Cancer. 3:807–821. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Cox CJ, Espinoza HM, McWilliams B,
Chappell K, Morton L, Hjalt TA, Semina EV and Amendt BA:
Differential regulation of gene expression by PITX2 isoforms. J
Biol Chem. 277:25001–25010. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Kioussi C, Briata P, Baek SH, Rose DW,
Hamblet NS, Herman T, Ohgi KA, Lin C, Gleiberman A, Wang J, et al:
Identification of a Wnt/Dvl/beta-Catenin ->Pitx2 pathway
mediating cell-type-specific proliferation during development.
Cell. 111:673–685. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Liu W, Selever J, Lu MF and Martin JF:
Genetic dissection of Pitx2 in craniofacial development uncovers
new functions in branchial arch morphogenesis, late aspects of
tooth morphogenesis and cell migration. Development. 130:6375–6385.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Iwata J, Tung L, Urata M, Hacia JG,
Pelikan R, Suzuki A, Ramenzoni L, Chaudhry O, Parada C,
Sanchez-Lara PA and Chai Y: Fibroblast growth factor 9
(FGF9)-pituitary homeobox 2 (PITX2) pathway mediates transforming
growth factor β (TGFβ) signaling to regulate cell proliferation in
palatal mesenchyme during mouse palatogenesis. J Biol Chem.
287:2353–2363. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Hirose H, Ishii H, Mimori K, Tanaka F,
Takemasa I, Mizushima T, Ikeda M, Yamamoto H, Sekimoto M, Doki Y
and Mori M: The significance of PITX2 overexpression in human
colorectal cancer. Ann Surg Oncol. 18:3005–3012. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Fung FK, Chan DW, Liu VW, Leung TH, Cheung
AN and Ngan HY: Increased expression of PITX2 transcription factor
contributes to ovarian cancer progression. PLoS One. 7:e370762012.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Vinarskaja A, Schulz WA, Ingenwerth M,
Hader C and Arsov C: Association of PITX2 mRNA down-regulation in
prostate cancer with promoter hypermethylation and poor prognosis.
Urol Oncol. 31:622–627. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Berx G and van Roy F: Involvement of
members of the cadherin superfamily in cancer. Cold Spring Harb
Perspect Biol. 1:a0031292009. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Widschwendter M, Fiegl H, Egle D,
Mueller-Holzner E, Spizzo G, Marth C, Weisenberger DJ, Campan M,
Young J, Jacobs I and Laird PW: Epigenetic stem cell signature in
cancer. Nat Genet. 39:157–158. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
65
|
Widschwendter M, Apostolidou S, Raum E,
Rothenbacher D, Fiegl H, Menon U, Stegmaier C, Jacobs IJ and
Brenner H: Epigenotyping in peripheral blood cell DNA and breast
cancer risk: A proof of principle study. PLoS One. 3:e26562008.
View Article : Google Scholar : PubMed/NCBI
|
